Abstract:OBJECTIVE To analyze the expressions of Ki67, PCNA and mitotic index in ovarian epithelial tumors and their relationship with clinical pathological features. METHODS The expressions of Ki67, PCNA protein and mitotic index in ovarian tissues from 20 patients with normal ovarian tissues, 28 patients with ovarian benign tumors, 20 patients with borderline tumors and 109 (73 metastatic ovarian cancer) patients with malignant tumors were retrospectively tested using the American GBI immunohistochemistry two-step method. The expressions of Ki67 and PCNA mRNA were also detected by in situ hybridization (ISH) in ovarian tissues from 37 patients with primary ovarian cancer, 14 patients with borderline tumors, 11 patients with benign tumors and 12 patients with normal ovarian tissues. The relationship between clinical pathologic parameters and the expressions of Ki67 and, PCNA and mitotic index in human ovarian tumors was analyzed. RESULTS (1) The expressions of Ki67 mRNA and protein in ovarian epithelial tumors was higher than in the controls (P = 0.003; P = 0.009; P = 0.001; P = 0.001). But no significant differences appeared in the expression and overexpression of PCNA mRNA and pratein (P = 0.327; P = 0.718; P = 0.123; P = 0.125). Positive correlations between the expressions of mRNA and protein for Ki67 and PCNA were found (r = 0.449, P = 0.025; r = 0.484, P = 0. 014). (2) The expression of Ki67 in ovarian epithelial was higher in low differential carcinoma and at FIGO III-IV stage (P = 0.008; P = 0.007). The expression of Ki67 protein in serous tumor tissues was high, but low or missed in other types of tumor tissues such as malignant mixed mullerian tumor and transitional cell carcinoma (P = 0. 018). No significant differences in other clinicopathological features were found. The high expression of PCNA did not coincide with histological grading, clinical stage and histological types (P = 0.447; P = 0.763; P = 0.657). There were 72 patients with high mitotic index (66.1%). The high expression of mitotic index coincided with histological grading and clinical stage, but not with histological types (P = 0.002; P = 0.040). (3) The combined overexpression of Ki67 and high mitotic index occurred in 57 patients, which coincided with histological grading, clinical stage and histological types (P = 0.018; P = 0.001; P = 0.020). (4) In the 73 patients with metastatic ovarian cancers, the expressions of Ki67 (58.9%), PCNA protein (91.8%) and high MI (61.6%) in primary cancer tissues were greater than in the metastatic cancer tissues (peritoneum and epiploon, Ki67 41.4%, P = 0.031; PCNA 74%, P = 0.004; high MI 38.4%, P = 0.005). The positive intensity of Ki67 protein expression in primary ovarian cancers was significantly higher than in metastatic ovarian cancers (P = 0.040). There was no significant difference in positive intensity of PCNA between primary and metastatic ovarian cancers (P = 0.514). CONCLUSION Ki67 and mitotic index can serve as biomolecular markers for predicting the proliferation of malignant ovarian epithelial tumors. PCNA can not discriminate between benign and malinant ovarian tumors.

Expressions of Beta-catenin, E-cadherin and MMP-7 in Ovarian Epithelial Tumors

Expressions of Beta-Catenin, APC Protein, C-myc and Cyclin D1 in Ovarian Epithelial Tumor and Their Implication

Expression of Beta-Catenin and APC Protein in Ovarian Epithelial Tumor and Its Implication

Clinical Significance Of Ngal And Mmp-9 Protein Expression In Epithelial Ovarian Cancers

Expression and clinical significance of P16, P15,and VEGF proteins in primary epithelial ovarian carcinoma

Expressions of E-cadherin and β-catenin in human primary epithelial ovarian carcinomas and their clinical significance

Expression and clinical significance of MMP-2 and VEGF protein in epithelial ovarian tumors

Expressions of MMP-9 and E-cadherin in colorectal carcinoma and their clinical significance

Expressions of LN, MMP and Microvessel Density in Ovarian Tumors

VEGF, VEGFRs Expressions and Activated STATs in Ovarian Epithelial Carcinoma

The expression and clinicopathological significance of E-cadherin,β-catenin and p120 in epithelial ovarian carcinoma

Expression of EGFR and MMP-9 in epithelial ovarian cancer and their correlation with prognosis of patients

The Expression and Clinical Significance of Matrix Metalloproteinase-9 and Vascular En-Dothelial Growth Factor in Ovarian Cancer Tissue

The Expression of P~(73)、CD59、MMP-19 in Epithelial Ovarian Cancer and Borderlane Tumors

Expression and significance of beta-catenin, Glut-1 and PTEN in proliferative endometrium, endometrial intraepithelial neoplasia and endometrioid adenocarcinoma.

Experssion of Beclin1 and PTEN Protein and Their Relationship with Clinic Characteristic of Epithelial Ovarian Cancer

[Expressions of Ki67, PCNA and Mitotic Index in Ovarian Epithelial Tumors].

Expression of MMP-2、MMP-9 、TIMP-2 and Infection of Bacterial L-forms in Ovarian Neoplasms and Its Clinical Significance

Expression of E-cadherin, β-catenin, MMP-7 and their significances in cholangiocarcinoma

Expression of PAX8, Tubulin and Calretinin in ovarian mucinous tumors and clear cell cancer

Clinical Significance of the Expression of Osteopontin and MMP-9 in Breast Cancer